España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Xenetic Biosciences
XBIO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.29
0.01000
0.23%
At close: -
$3.93
-0.36
-8.39%
After Hours: Dec 19, 4:23 PM EDT
Get Report
Comment
Xenetic Biosciences (XBIO) Forecast
News
Earnings
Xenetic Biosciences (XBIO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Xenetic Biosciences (NASDAQ:XBIO) Stock
Xenetic Biosciences Stock (NASDAQ: XBIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
Xenetic Biosciences Extends Research Agreemen...
Benzinga Newsdesk
Thursday, December 05, 2024
HC Wainwright & Co. Reiterates Neutral on Xen...
Benzinga Newsdesk
Xenetic Biosciences Signs Clinical Trial Serv...
Benzinga Newsdesk
Friday, November 22, 2024
HC Wainwright & Co. Reiterates Neutral on Xen...
Benzinga Newsdesk
Thursday, November 21, 2024
Xenetic Biosciences Presents Preclinical Data...
Benzinga Newsdesk
Wednesday, November 13, 2024
Xenetic Biosciences Q3 EPS $(0.28) Misses $(0...
Benzinga Newsdesk
Tuesday, November 12, 2024
Xenetic Biosciences Presents Data Demonstrati...
Benzinga Newsdesk
Thursday, November 07, 2024
Xenetic Biosciences Extends Collaboration Wit...
Benzinga Newsdesk
Thursday, October 17, 2024
Xenetic Biosciences Enters Materials Transfer...
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Tuesday, August 20, 2024
HC Wainwright & Co. Reiterates Neutral on Xen...
Benzinga Newsdesk
Wednesday, August 14, 2024
Xenetic Biosciences Q2 EPS $(0.83) Misses $(0...
Benzinga Newsdesk
Friday, May 10, 2024
Xenetic Biosciences Reports Q1 Loss, Misses Revenue Estimates
Zacks
Xenetic Biosciences Q1 2024 GAAP EPS $(0.78) ...
Benzinga Newsdesk
Monday, March 25, 2024
CORRECTION: On Friday, Xenetic Biosciences Q4...
Benzinga Newsdesk
Wednesday, January 17, 2024
Xenetic Biosciences Enters Into Research Agre...
Benzinga Newsdesk
Tuesday, December 05, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Friday, November 10, 2023
Xenetic Biosciences: Q3 Earnings Insights
Benzinga Insights
Xenetic Biosciences Q3 EPS $(0.69) Beats $(1....
Benzinga Newsdesk
Friday, August 11, 2023
Xenetic Biosciences Reports Q2 Net Loss $(1.1...
Benzinga Newsdesk
Tuesday, June 20, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, May 16, 2023
Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences
Vandana Singh
HC Wainwright & Co. Downgrades Xenetic Biosci...
Benzinga Newsdesk
Monday, May 15, 2023
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Friday, May 12, 2023
Xenetic Biosciences shares are trading lower ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Xenetic Biosciences, Inc. Announces 1-For-10 Reverse Stock Split Of Common Stock
Happy Mohamed
Thursday, April 13, 2023
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh
Wednesday, April 12, 2023
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh
Tuesday, April 11, 2023
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Xenetic Biosciences, Inc. Announces Research And Development Collaboration With The Scripps Research Institute To Advance DNase Platform
Happy Mohamed
Thursday, March 16, 2023
US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh
Thursday, March 02, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, March 01, 2023
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh
Monday, February 06, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Tuesday, January 17, 2023
Xenetic Biosciences, Inc. Announces Notice Of...
Benzinga Newsdesk
Monday, December 19, 2022
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, December 16, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, November 30, 2022
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, November 16, 2022
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Thursday, November 10, 2022
Xenetic Biosciences Says Ended Q3 2022 With $...
Benzinga Newsdesk
Friday, October 28, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, October 12, 2022
Xenetic Biosciences Says Co. Entered Into Sub...
Michael Horton
Tuesday, October 11, 2022
Xenetic Biosciences, Inc. Announces Signing Of Patent Assignment Related To Collaboration With VolitionRx Limited And CLS Therapeutics
Bill Haddad
Friday, August 12, 2022
Xenetic Biosciences Cash Position $14.9M
Bill Haddad
Tuesday, August 02, 2022
Xenetic Biosciences, VolitionRx Limited Colla...
Benzinga Newsdesk
Wednesday, May 04, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch